Health Canada drug identification number

DIN 00723770 — XANAX 1 MG

XANAX is a tablet of Alprazolam marketed by BGP PHARMA ULC. The full Alprazolam monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
00723770
Brand name
XANAX
Active ingredient
Alprazolam
Strength
1 MG
Dosage form
TABLET
Route
ORAL
Manufacturer
BGP PHARMA ULC
Health Canada status
MARKETED
Drug class
Benzodiazepine (anxiolytic-antipanic agent)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Alprazolam products

DINBrandStrengthFormManufacturerStatus
00865397 APO-ALPRAZ 0.25 MG TABLET APOTEX INC MARKETED
00865400 APO-ALPRAZ 0.5 MG TABLET APOTEX INC MARKETED
02243611 APO-ALPRAZ 1 MG TABLET APOTEX INC MARKETED
02243612 APO-ALPRAZ TS 2 MG TABLET APOTEX INC MARKETED
01908189 PRO-ALPRAZOLAM 0.25 MG TABLET PRO DOC LIMITEE MARKETED
01908170 PRO-ALPRAZOLAM 0.5 MG TABLET PRO DOC LIMITEE MARKETED
02248706 PRO-ALPRAZOLAM 1 MG TABLET PRO DOC LIMITEE MARKETED
01913484 TEVA-ALPRAZOLAM 0.25 MG TABLET TEVA CANADA LIMITED MARKETED
01913492 TEVA-ALPRAZOLAM 0.5 MG TABLET TEVA CANADA LIMITED MARKETED
00548359 XANAX 0.25 MG TABLET BGP PHARMA ULC MARKETED
00548367 XANAX 0.5 MG TABLET BGP PHARMA ULC MARKETED
00813958 XANAX TS 2 MG TABLET BGP PHARMA ULC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.